Takeda Pharmaceutical Co Ltd (TSE:4502)
円 4205 103 (2.51%) Market Cap: 6.60 Til Enterprise Value: 10.97 Til PE Ratio: 46.05 PB Ratio: 0.91 GF Score: 76/100

Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 10:20PM GMT
Release Date Price: 円3695
Seiji Wakao
JPMorgan Chase & Co, Research Division - VP

Good afternoon, everyone. Welcome to the JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan Pharma analyst in JPMorgan. And it's my pleasure to introduce Christophe Weber, CEO of Takeda, and welcome him to the conference.

The presentation will be followed directly by Q&A. Audience can submit questions anytime by using the ask a question on the (inaudible) conference book, resend your questions.

With that, let me turn it over to Christophe.

Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director

Thank you, Wakao San, and hello, everyone. It's my great pleasure to be with you today even if remotely. I'm really delighted to update you on Takeda and our progress, especially because this year 2021 will be clearly a very inflection -- a very special inflection year for Takeda.

I'll go through the presentation, and I will say the slide numbers, so that you can follow. On Slide #2, the traditional notice regarding forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot